HCP PRINT CAMPAIGN for MULTIPLE MYELOMA

Multiple Myeloma patients are never cured; they experience bouts of remission and relapse. Ideally, patients could stay on treatment longer in order to enjoy a longer remission. However, many of the drugs in the category can become so intolerable that physicians cut treatment short.
With this new drug, patients can stay on treatment longer, continue fighting the cancer, and suffer from fewer adverse effects.